Angiotensin I-converting enzyme inhibitory (ACEI) peptides have attracted increased research attention owing to their ability to effectively inhibit ACE activity and their significant effects on the prevention and treatment of hypertension [11]. The gene discussed is ACE; the disease is hypertensive disorder.